title: Global development of resistance--secondary publication.
abstract: Antibiotic resistance is an increasing problem world wide, although in some areas the increase in resistance is slow, as in the Nordic countries. Multiresistant staphylococci, Enterobacteriaceae and Mycobacterium tuberculosis are already causing increased morbidity, mortality and huge costs in health budgets. New effective antibiotics will not be available for the next 10-15 years, since the pharmaceutical industry has lost interest in antibiotics. The major determinant in this field, in order to save the activity of the known antibiotics, is the control of antibiotic use.
authors.affiliation: National Center for Antimicrobials and Infection Control, Statens Serum Institut, 2300 Copenhagen S. Denmark. nfm@ssi.dk
authors.forename: Niels
authors.initials: N
authors.lastname: Frimodt-Møller
authors.forename: Anette M
authors.initials: AM
authors.lastname: Hammerum
authors.forename: Line
authors.initials: L
authors.lastname: Bagger-Skjøt
authors.forename: Jonas H R
authors.initials: JH
authors.lastname: Hessler
authors.forename: Christian T
authors.initials: CT
authors.lastname: Brandt
authors.forename: Robert L
authors.initials: RL
authors.lastname: Skov
authors.forename: Dominique L
authors.initials: DL
authors.lastname: Monnet
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends; D003718:Denmark; D004351:Drug Resistance; D014943:Global Health; D006801:Humans; D007391:International Cooperation; D011159:Population Surveillance / Q000379:methods
chemical_list: D000900:Anti-Bacterial Agents